Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	Health Council of the Netherlands Gezondheidsraad (GR)	4,4'-Methylenedianiline - Health-based calculated occupational cancer risk values
2015	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab. NICE technology appraisal guidance 357
2015	NIHR Health Technology Assessment programme	Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Pre-operative cardiovascular surgery patient education
2015	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of open mesh repairs in adults presenting with a clinically diagnosed primary unilateral inguinal hernia who are operated in an elective setting: systematic review and economic evaluation
2015	Health Council of the Netherlands Gezondheidsraad (GR)	1,4-Dioxane - re-evaluation of the carcinogenicity and genotoxicity
2015	National Institute for Health and Care Excellence (NICE)	Tolvaptan for treating autosomal dominant polycystic kidney disease. NICE technology appraisal guidance 358
2015	Health Council of the Netherlands Gezondheidsraad (GR)	2,6-Xylidine - re-evaluation of the carcinogenicity and genotoxicity
2015	National Institute for Health and Care Excellence (NICE)	Idelalisib for treating chronic lymphocytic leukaemia. NICE technology appraisal guidance 359
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Methodology for the evaluation of the evidence for the Dutch dietary guidelines 2015 - background document
2015	National Institute for Health and Care Excellence (NICE)	Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal). NICE technology appraisal guidance 362
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Inpatient mental health unit décor
2015	Health Council of the Netherlands Gezondheidsraad (GR)	Shiftwork and health risks: possibilities for prevention
2015	National Institute for Health and Care Excellence (NICE)	Ledipasvir-sofosbuvir for treating chronic hepatitis C. NICE technology appraisal guidance 363
2015	National Institute for Health and Care Excellence (NICE)	Ombitasvir-paritaprevir-ritonavir with or without dasabuvir for treating chronic hepatitis C. NICE technology appraisal guidance 365
2015	Health Information and Quality Authority (HIQA)	Guidance on budget impact analysis of health technologies in Ireland
2015	NIHR Health Technology Assessment programme	Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report
2015	Penn Medicine Center for Evidence-based Practice (CEP)	Locking solutions for central venous catheters
2015	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for advanced melanoma not previously treated with ipilimumab. NICE technology appraisal guidance 366
2015	NIHR Health Services and Delivery Research programme	Tele-First: telephone triage as an alternative to face to face contact in general practice
2015	National Institute for Health and Care Excellence (NICE)	Vortioxetine for treating major depressive episodes. NICE technology appraisal guidance 367
2015	NIHR Health Technology Assessment programme	The relative clinical and cost-effectiveness of three contrasting approaches to partner notification for curable sexually transmitted infections (STIs): a cluster randomised trial in primary care
2015	NIHR Health Services and Delivery Research programme	Intentional rounding in hospital wards: What works, for whom and in what circumstances?
2015	National Institute for Health and Care Excellence (NICE)	Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears. NICE technology appraisal guidance 369
2015	National Institute for Health and Care Excellence (NICE)	Bortezomib for previously untreated mantle cell lymphoma. NICE technology appraisal guidance 370
2015	NIHR Health Technology Assessment programme	Clinical diagnostic accuracy of rapid detection of healthcare-associated bloodstream infection in critical care using multi-pathogen real-time polymerase chain reaction (RT-PCR) technology
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Lonsurf (trifluridine and tipiracil hydrochloride) for metastatic colorectal cancer – third line
2015	National Institute for Health and Care Excellence (NICE)	Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis. NICE technology appraisal guidance 373
2015	NIHR Horizon Scanning Centre (NIHR HSC)	AZD9291 for locally advanced or metastatic, EGFR and T790M mutation positive non-small cell lung cancer – second line
2015	Institute of Health Economics (IHE)	A systematic review of the measurement properties of self-report instruments that assess presenteeism
2015	NIHR Health Technology Assessment programme	The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
2015	NIHR Health Services and Delivery Research programme	The SHAPE project: Supporting adults with High-functioning Autism and asPerger syndromE. Mapping and evaluating specialist autism team service models
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Sodium thiosulfate for prevention of hearing loss in children receiving cisplatin chemotherapy
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ipilimumab (Yervoy) for small cell lung cancer – first line, in combination with etoposide and platinum therapy
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib for metastatic uveal melanoma – first line
2015	NIHR Health Services and Delivery Research programme	Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ibrutinib (Imbruvica) for Waldenström's macroglobulinaemia
2015	NIHR Health Technology Assessment programme	Diagnostic accuracy of the Thessaly test, standardised clinical history and other clinical examination tests (Apley's, McMurray's and joint line tenderness) for meniscal tears in comparison with magnetic resonance imaging diagnosis
2015	NIHR Health Services and Delivery Research programme	The value and cost of different forms of information on oral health status and risk given to patients following a check-up in dental practice
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Nimotuzumab for advanced pancreatic cancer – second line
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Public health interventions to reduce the secondary spread of measles
2015	NIHR Health Technology Assessment programme	Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation
2015	NIHR Health Technology Assessment programme	The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation
2015	NIHR Health Technology Assessment programme	The PAndemic INfluenza Triage in the Emergency Department (PAINTED) pilot cohort study
2015	Belgian Health Care Knowledge Centre (KCE)	Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Evofosfamide for locally advanced, unresectable or metastatic pancreatic cancer – first line in combination with gemcitabine
2015	Belgian Health Care Knowledge Centre (KCE)	Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening
2015	HAYES, Inc.	Absorbable perirectal spacer (SpaceOAR System; Augmenix Inc.) during radiation therapy for prostate cancer
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ixekizumab for moderate to severe chronic plaque psoriasis
2015	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-term use of acamprosate calcium for alcoholism: a review of the clinical effectiveness, safety, and guidelines
2015	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of parenting interventions for children with severe attachment problems: a systematic review and meta-analysis
2015	Belgian Health Care Knowledge Centre (KCE)	Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology
2015	HAYES, Inc.	Adalimumab (humira) for treatment of pediatric Crohn's disease
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators
2015	NIHR Health Technology Assessment programme	Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis
2015	Belgian Health Care Knowledge Centre (KCE)	Cardiovascular pre-participation screening in young athletes
2015	HAYES, Inc.	Augment bone graft (Wright Medical Group Inc.) for bone regeneration in ankle and/or hindfoot fusions
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for amyotrophic lateral sclerosis – add-on therapy to riluzole
2015	NIHR Health Technology Assessment programme	Rapid detection of health-care-associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic review
2015	Belgian Health Care Knowledge Centre (KCE)	Non-invasive markers of subclinical atherosclerosis for predicting a primary cardiovascular event: a rapid systematic review
2015	HAYES, Inc.	Eliglustat (Cerdelga) for Gaucher disease type 1
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Reslizumab for eosinophilic asthma
2015	NIHR Health Technology Assessment programme	Double-blind randomised controlled trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in the treatment of faecal incontinence: CONtrol of Faecal Incontinence using Distal NeuromodulaTion (the CONFIDeNT trial)
2015	NIHR Public Health Research (PHR) programme	Preschoolers in the Playground: a pilot cluster randomised controlled trial of a physical activity intervention for children aged 18 months to 4 years
2015	HAYES, Inc.	Elosulfase alpha (Vimizim) for treatment of Morquio A Syndrome
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Biotin (Cerenday) for primary and secondary progressive multiple sclerosis - first line
2015	NIHR Health Technology Assessment programme	An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care
2015	HAYES, Inc.	Flibanserin (Addyi) for premenopausal women with hypoactive sexual desire disorder
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Sodium zirconium cyclosilicate for hyperkalaemia – first line
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Endovenous interventions on varicose veins of the leg
2015	Agency for Healthcare Research and Quality (AHRQ)	Menopausal symptoms: comparative effectiveness review of therapies
2015	Agency for Healthcare Research and Quality (AHRQ)	Public reporting of cost measures in health: an environmental scan of current practices and assessment of consumer centeredness
2015	Scottish Health Technologies Group (SHTG)	Magnetic resonance guided focused ultrasound surgery (MRgFUS) for the treatment of uterine fibroids
2015	HAYES, Inc.	iFuse implant system (SI-BONE Inc.) for sacroiliac joint fusion for treatment of low back pain
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Simeprevir in combination with sofosbuvir (with or without ribavirin) for chronic hepatitis C
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Hypoglossal nerve stimulation (HGNS) for treatment of obstructive sleep apnea
2015	NIHR Health Technology Assessment programme	A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT
2015	Agency for Healthcare Research and Quality (AHRQ)	Treatments for Fibromyalgia in Adult Subgroups
2015	NIHR Health Services and Delivery Research programme	Evaluating the evidence on employee engagement and its potential benefits to NHS staff: a narrative synthesis of the literature
2015	HAYES, Inc.	Intravenous golimumab (Simponi Aria) for treatment of active rheumatoid arthritis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Sarilumab for moderate to severe active rheumatoid arthritis
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Prophylactic insertion of a gastrostomy for nutritional support in patients with head and neck cancer
2015	NIHR Health Technology Assessment programme	Initiating change locally in bullying and aggression through the school environment (INCLUSIVE): a pilot randomised controlled trial
2015	NIHR Health Technology Assessment programme	Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation
2015	Agency for Healthcare Research and Quality (AHRQ)	Pain management injection therapies for low back pain
2015	HAYES, Inc.	Laminotomy for lumbar spinal stenosis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Tofacitinib for chronic plaque psoriasis – second line
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Oncological safety and patient-related outcomes of autologous fat grafting in breast reconstruction after breast cancer surgery
2015	NIHR Health Technology Assessment programme	Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model
2015	Agency for Healthcare Research and Quality (AHRQ)	Routine iron supplementation and screening for iron deficiency anemia in children ages 6 to 24 months: a systematic review to update the U.S. Preventive Services Task Force Recommendation
2015	HAYES, Inc.	Liraglutide (Saxenda) for weight loss in non-diabetic obese adults
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Cx601 (Alofisel®) for complex perianal fistula in adults with non-active or mildly-active luminal Crohn's disease – second line
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Drug eluting balloons and stents for symptomatic peripheral arterial disease
2015	NIHR Health Technology Assessment programme	A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study
2015	NIHR Health Technology Assessment programme	Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme
2015	Agency for Healthcare Research and Quality (AHRQ)	Management of postpartum hemorrhage
2015	HAYES, Inc.	Lumacaftor-ivacaftor (Orkambi) for treatment of cystic fibrosis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Tildrakizumab for moderate to severe plaque psoriasis
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Transcranial Magnetic Resonance Guided Focused Ultrasound treatment of essential tremor, neuropathic pain and Parkinson's disease
2015	NIHR Health Technology Assessment programme	The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis